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Community prevalence of antibodies to
human immunodeficiency virus in rural
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ABSTRACT
Background. Human immunodeficiency virus
(HIV) infection and acquired immunodefi-
ciency syndrome (AIDS) are becoming increas-
ingly common in India. Currently, antenatal
prevalence is a surrogate marker for HIV
prevalence in the community. The association
between antenatal and community prevalence
of HIV needs to be validated so that estimates
can be verified or adjusted appropriately.
Methods. A probability proportional to size cluster survey
was conducted in the Kaniyambadi block of Vellore district and
in the urban wards of Vellore town to estimate the prevalence of
antibodies to rubella from August 1999 to February 2000. All
personal identifier data from the serum samples were removed
to yield a collection for which only the age and sex were known.
Estimation of antibodies to HIV in sera from individuals between
15 and 40 years of age, was carried out by one screening ELISA
and the reactive sera were further subjected to a supplementary
test.
Results. We tested 1512 serum samples from subjects
residing in rural areas and 1358 samples from those residing in
urban areas. The seropositivity among rural samples was 0.66%
and among urban samples 1.4%. The prevalence was almost
equal among men and women and the youngest infected
individual was 15 years old.
Conclusion. The prevalence of HIV during the period of
study was similar to the national surveillance data for Tamil Nadu
based on antenatal women. HIV prevalence differs in urban and
rural Tamil Nadu, with urban areas having a higher burden of the
disease.
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INTRODUCTION
The number of human immunodeficiency virus (HIV)-infected
individuals in India is estimated to be 5.1 million. This estimate
is based on the surveillance carried out by the National AIDS
Control Organization (NACO) through its sentinel centres across
the country which submit data from sexually transmitted disease
(STD) and antenatal clinics. In 2002, in Tamil Nadu, the estimated
prevalence of antibodies to HIV based on antenatal clinic data was
0.88%, while it had previously been 1% or higher.1 Antenatal HIV
prevalence is a surrogate marker which needs validation by
community studies. Such validation is not available because
previous studies to estimate HIV prevalence have been carried out
in communities that are at high risk for HIV infection, or have been
biased by recruitment of individuals attending health camps or
STD screening camps.2–4 Community prevalence of HIV infection
ranged from 1.8% to 7.4% in studies carried out in Tamil Nadu,2,3
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which is significantly higher than that reported for antenatal
screening. We did a seroprevalence survey using unlinked samples
that were collected for a different infectious disease (rubella).
METHODS
The serum samples used in this study were collected from August
1999 to February 2000 during a survey for rubella. The sampling
methods are briefly described below.
Rural community survey
The Kaniyambadi block of Vellore district consists of 88 villages.
A database updated by the 1994 and 1999 censuses of the block
was used as the sampling frame for the survey. Demographic
summaries obtained from this database were used for planning the
various stages of the sample selection procedure. Villages were
divided into two strata based on the population size (£2000 and
>2000 population). As approximately 50% of the population was
in each strata, half the survey population was selected from each
stratum. Twenty clusters were selected in each stratum using
probability proportional to size (PPS), based on the cumulative
population size of those up to 40 years of age in each village, with
serum samples being collected from those in the age group of
3–40 years. Thirty households within each cluster were selected
by simple random sampling (SRS). The sample size for each
cluster was based on the total sample size divided by the number
of clusters, with an adjustment to allow for ineligible households
and non-response. Compliance with sample collection was 94.8%.
Urban community survey
The Vellore municipality is divided into 49 wards with 5 urban
health centres. The database used for the sampling framework was
the 1999 census conducted by the health centres. The age group
5–44 years was used for estimation of the sample size, although
serum samples were collected again only in the age group of 3–40
years. Eighty clusters (streets) were selected by PPS based on the
total population, with 12 households (families) selected by SRS
from each street. Forty clusters were selected from streets with a
population size <556, and 40 clusters from streets with a popula-
tion size >556. Compliance with sample collection was 87.7%.
Laboratory testing
The serum samples were delinked from all personal identifiers
except age and sex and tested in batches. Sera from individuals
>15 years of age were selected for testing. The first screening
ELISA was Genedia HIV-1 and -2, in which all positive samples
were tested twice, followed by the Detect HIV ELISA for confir-
mation as recommended by the WHO for developing countries.
The use of unlinked, anonymized sera was approved by the
institutional research committee.
Statistical analysis
SPSS version 6 and STATA software were used for data analysis.
The probability of selection for age and sex distribution was
obtained from the 1994 and 1999 censuses for rural and urban
populations, respectively. The prevalence and confidence inter-
vals were estimated, incorporating adjustment for design effect.
RESULTS
The age distribution and positivity rates for each age group are
given in Table I. Of the 2870 samples tested, 29 were positive,
giving a prevalence of 1.01%. A total of 1512 samples from
individuals in rural areas were tested, of which 10 (5 men and 5
women) were confirmed to be positive (0.66%; 95% CI: 0.5–0.8).
The age of the youngest infected individual was 15 years, the
starting age of the sampling. In the rural samples, there were two
samples from a single cluster, one from a 37-year-old man and the
other a 31-year-old woman. Of the 1358 samples from urban
individuals, 19 (9 women and 10 men) were positive (1.4%; 95%
CI:1.2–1.6). The youngest infected individual was 15 years of age.
There were four clusters with more than 1 positive individual,
three clusters had 2 positive individuals each (2 women, 2 men,
and 1 man and 1 woman) and one cluster had 3 positive individu-
als (2 men and a woman).
In both rural and urban populations, all infected individuals
below the age of 25 years were women. In both rural and urban
populations, the highest prevalence of HIV infection was in the
age group of 30–34 years, with 4% and 1.53% in the urban and
rural populations, respectively. The difference in prevalence be-
tween the rural and urban population was statistically significant
(p<0.001, chi-square test).
DISCUSSION
Previous studies on the prevalence of antibodies to HIV carried
out in Tamil Nadu have focused on high risk groups such as
patients attending STD clinics and those with tuberculosis. The
NACO STD clinic surveillance data from Tamil Nadu for the
past 5 years shows an HIV prevalence of over 10%.1 For 1999
and 2000, the period during which the samples analysed in this
study were collected, the prevalence in STD clinics of Tamil
Nadu was 16.3% and 10.4%, respectively, with an antenatal
prevalence of 1%.
A study carried out to estimate HIV seroprevalence among
patients with tuberculosis in Tamil Nadu during 1997–98 showed
that in Vellore, the District Tuberculosis Centre and the Sanato-
rium had a seroprevalence of 4.3% and 9.4%, respectively.4 In
another study on patients with tuberculosis from Chennai, the
HIV seroprevalence was 16.9%.5 Other populations in whom
HIV seroprevalence has been estimated in Tamil Nadu include
patients with leprosy and mental disroders.6,7 Unlike patients
attending STD clinics and those presenting with tuberculosis,
patients with leprosy and mental disorders did not appear to be
high risk populations based on seroprevalence data. Studies
from other parts of India have also reported an increasing
incidence of HIV infection in STD clinic attendees and patients
with tuberculosis.8–12
Different approaches have been used in various studies to
establish community prevalence in Tamil Nadu. In a study carried
out in 1994 and 1995 in 5 urban and 5 rural centres, where every
third adult was recruited, HIV-1 antibodies were found in 7.4%
(95% CI: 5.8%–9.2%) of urban and 7% (95% CI: 5.6%–8.7%) of
the rural population, which is significantly higher than that
reported by the national surveillance data.3 In a more recently
published study that utilized a cluster sampling model in 3
TABLE I. Seroprevalence of antibodies to human immunodeficiency
virus (HIV) infection in the urban and rural areas of Vellore
Age group Urban Rural
 (in years) n Positive (%) n Positive (%)
15–19 336 1 (0.3) 403 1 (0.25)
20–24 291 2 (0.69) 299 1 (0.33)
25–29 280 5 (1.79) 282 1 (0.35)
30–34 225 9 (4) 262 4 (1.53)
35–40 226 2 (0.88) 266 3 (1.13)
Total 1358 19 (1.4) 1512 10 (0.66)
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districts of Tamil Nadu where individuals were recruited for STD
screening, an HIV prevalence of 1.8% (95% CI: 1.7–1.9) was
found.2 The use of study designs which involve purposeful, non-
random selections introduces a bias because persons likely to have
the disease will attend such camps, making it difficult to general-
ize these data to the community.
In our study, sera were collected for an infectious disease
survey which has no associated stigma, and compliance with
sample collection was high. Therefore, the results obtained can be
generalized to the population under consideration. The combined
HIV prevalence for the rural and urban populations in this study
was 1%, which is the same as the NACO antenatal surveillance
data for 1999 and 2000.
The major lacunae in our study are the inability to assess risk
factors because of the unlinked, anonymized testing and the lack
of availability of samples from persons over 40 years of age.
However, the data reported here validate the approach of utilizing
antenatal surveillance to estimate HIV antibody prevalence, and
highlight the differences in rural and urban HIV prevalence.
Based on this and previous reports,2,3,13,14 as well as data submitted
annually to NACO from the surveillance centre in the Department
of Clinical Virology at Christian Medical College, it is seen that
the estimated doubling time in patients at Vellore is approxi-
mately 3.5 years. We conclude that while there is no dramatic
increase from year to year, the HIV epidemic is continuing to
spread in the general population.
ACKNOWLEDGEMENTS
Financial support for this study was received from the Tufts–Brown Fogarty
AIDS International Research and Training Program and the Tufts Center for
AIDS Research. Dr Felicity Cutts designed the original study on rubella.
REFERENCES
1 National AIDS Control Organization. Position statement. New Delhi:Ministry of
Health and Family Welfare; 2003.
2 Thomas K, Thyagarajan SP, Jeyaseelan L, Varghese JC, Krishnamurthy P, Bai L, et
al. Community prevalence of sexually transmitted diseases and human
immunodeficiency virus infection in Tamil Nadu, India: A probability proportional
to size cluster survey. Natl Med J India 2002;15:135–40.
3 Solomon S, Kumarasamy N, Ganesh AK, Amalraj RE. Prevalence and risk factors of
HIV-1 and HIV-2 infection in urban and rural areas in Tamil Nadu, India. Int J STD
AIDS 1998;9:98–103.
4 Ramachandran R, Datta M, Subramani R, Baskaran G, Paramasivan CN, Swaminathan
S. Seroprevalence of human immunodeficiency virus (HIV) infection among
tuberculosis patients in Tamil Nadu. Indian J Med Res 2003;118:147–51.
5 Samuel NM, Alamelu C, Jagannath K, Rajan B. Detection of HIV infection in
pulmonary tuberculosis patients. J Indian Med Assoc 1996;94:331–3.
6 Sekar B, Jayasheela M, Chattopadhya D, Anandan D, Rathinavel L, Vasanthi B, et al.
Prevalence of HIV infection and high-risk characteristics among leprosy patients of
south India. A case–control study. Int J Lepr Other Mycobact Dis 1994;62:527–31.
7 Tharyan P, Ramalingam S, Kannangai R, Sridharan G, Muliyil J, Tharyan A. Prevalence
of HIV infection in psychiatric patients attending a general hospital in Tamil Nadu,
south India. AIDS Care 2003;15:197–205.
8 Sharma SK, Aggarwal G, Seth P, Saha PK. Increasing HIV seropositivity among adult
tuberculosis patients in Delhi. Indian J Med Res 2003;117:239–42.
9 Gupta P, Kingsley L, Sheppard HW, Harrison LH, Chatterjee R, Ghosh A, et al. High
incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India.
Int J STD AIDS 2003;14:463–8.
10 Bairy I, Shivananda PG. Seroprevalence of HIV in Manipal. Indian J Med Sci
2001;55:257–62.
11 Kar HK, Jain RK, Sharma PK, Gautam RK, Gupta AK, Sharma SK, et al. Increasing
HIV prevalence in STD clinic attendees in Delhi, India: 6 year (1995–2000) hospital
based study results. Sex Transm Infect 2001;77:393.
12 Kulkarni MG, Kavishwar VS, Chogle AR, Parab VV, Aigal U, Koppikar GV.
Seroprevalence of human immunodeficiency virus infection in an infectious disease
hospital. J Assoc Physicians India 2000;48:1160–3.
13 Rose D, Sudarsanam A, Padankatti T, Babu PG, John TJ. Increasing prevalence of HIV
antibody among blood donors monitored over 9 years in one blood bank. Indian J Med
Res 1998;108:42–4.
14 Mehendale SM, Shepherd ME, Divekar AD, Gangakhedkar RR, Kamble SS, Menon
PA, et al. Evidence for high prevalence and rapid transmission of HIV among
individuals attending STD clinics in Pune, India. Indian J Med Res 1996;104:327–35.
An AIDS Helpline
The Centre for Community Medicine, All India Institute
of Medical Sciences, New Delhi through its AIDS
Education and Training Cell has started an interactive
AIDS helpline called Shubhchintak. This helpline aims
to create awareness about AIDS and answer queries
from the general public about AIDS and HIV infection.
This service works between 10 a.m. and 5 p.m. on all
working days from Monday to Friday. Telephonic ser-
vice is available on 011-26588333.
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